Does pollen exposure influence innate immunity to SARS-CoV-2 in allergy or asthma?
Description
No abstract
PubMed COVID-19 Clinical Care
44331 - 44340 of 58470 results found
Current regulatory landscape for viral point-of-care testing in the United States
Description
Historically, the diagnosis of viral infections has been accomplished using a combination of laboratory-based methods, including culture, serology, antigen-based tests, and molecular (e.g., real-time PCR) assays. Although these methods provide an
Improved accuracy and precision of fat-suppressed isotropic 3D T2 mapping MRI of the knee with dictionary fitting and patch-based denoising
Description
CONCLUSIONS: Improved accuracy and precision for isotropic 3D T2 mapping of knee cartilage were demonstrated by using patch-based image denoising and dictionary-based reconstruction.
Antibody titers after a third and fourth SARS-CoV-2 vaccine dose in Bizen City, Japan
Description
No abstract
Availability of information needed to evaluate algorithmic fairness - A systematic review of publicly accessible critical care databases
Description
CONCLUSION: This review demonstrates that critical care publicly available data used to train AI algorithms do not include enough information to properly look for intrinsic bias and fairness issues towards historically marginalized populations.
With the COVID-19 PHEIC over, what next?
Description
No abstract
Decay rate estimation of respiratory viruses in aerosols and on surfaces under different environmental conditions
Description
Majority of the viral outbreaks are super-spreading events established within 2-10 h, dependent on a critical time interval for successful transmission between humans, which is governed by the decay rates of viruses. To evaluate the decay rates of
The first year of the COVID-19 pandemic in humanitarian settings: epidemiology, health service utilization, and health care seeking behavior in Bangui and surrounding areas, Central African Republic
Description
CONCLUSIONS: A large underestimation of infections and decreased health care utilization characterized the first year of the COVID-19 pandemic in Bangui and surrounding area. Improved decentralized testing capacity and enhanced efforts to maintain
VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe
Description
CONCLUSIONS: The VACCELERATE Site Network enables a constantly updated Europe-wide mapping of experienced clinical sites interested in executing vaccine trials. The network is already in use as a rapid-turnaround single contact point for the